Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Jan 23, 2020 at 9:45 AM EST

Are Investors Overreacting to This Achromatopsia Study?

Applied Genetic Technologies' shares were crushed early on Thursday after the firm reported interim data from its midstage trial in…

Chris Lange | Jan 22, 2020 at 10:30 AM EST

Why This Cardiovascular Disease Study Could Be Huge

Akcea Therapeutics and Ionis Pharmaceuticals each made handy gains on Wednesday after the firms reported midstage results for their cardiovascular…

Jon C. Ogg | Jan 22, 2020 at 10:20 AM EST

Some Great News for Potential Alzheimer’s Treatment

Neurotrope released a corporate update after analyzing data from its recently reported Phase 2 confirmatory clinical trial examining moderately severe…

Paul Ausick | Jan 22, 2020 at 7:40 AM EST

Why Johnson & Johnson Stock Is Not Reacting More Positively to Earnings

Health care giant Johnson & Johnson reported fourth-quarter and full-year 2019 results Wednesday morning. The company posted narrow beats and…

Chris Lange | Jan 21, 2020 at 1:00 PM EST

China’s Coronavirus Could Prompt Buying Frenzy in These Biotech Stocks

China is facing an outbreak of the coronavirus, which may have spread to a few other countries in Asia. As…

Jon C. Ogg | Jan 21, 2020 at 10:15 AM EST

FDA Fast Track on Lung Cancer Treatment Brings Exponential Gains for This Microcap Stock

When companies see their shares rise by 100% or more in a single day, it's usually because of a buyout…

Chris Lange | Jan 21, 2020 at 10:00 AM EST

Winning Ideas in Biotech/Pharma After JPMorgan Healthcare Conference

For health care investors, 2020 looks like a potentially good year after an especially fruitful JPMorgan Healthcare Conference this past…

Douglas A. McIntyre | Jan 21, 2020 at 6:15 AM EST

China Virus: A Black Swan?

Rarely does a disease spread fast enough and is labeled dangerous enough that it quickly gets the attention of the…

Chris Lange | Jan 18, 2020 at 8:45 AM EST

This Week’s Biggest Biotech Movers

This past week played host to a huge number of biotech movers. 24/7 Wall St. has picked a few of…

Chris Lange | Jan 17, 2020 at 9:45 AM EST

What’s Next for Durect After FDA Posimir Vote

Durect shares dropped early on Friday after an FDA committee vote on Posimir, the company’s pain relief treatment.

Chris Lange | Jan 16, 2020 at 11:20 AM EST

Are Neon Therapeutics’ Shareholders Getting Enough in the Buyout?

Neon Therapeutics shares shot up on Thursday after the firm announced that it will be acquired by BioNTech. Are Neon…

Chris Lange | Jan 15, 2020 at 1:06 PM EST

Why This Opioid Painkiller Is Killing Nektar Therapeutics Stock

Nektar Therapeutics shares were crushed on Wednesday after the FDA did not recommend the company’s pain drug.

Chris Lange | Jan 15, 2020 at 11:40 AM EST

Does FDA Decision Mean a Bright Future for This Flu Vaccine?

An FDA nod for NanoFlu, a recombinant quadrivalent seasonal influenza vaccine candidate, offered a boost to Novavax shares on Wednesday.

Chris Lange | Jan 15, 2020 at 9:45 AM EST

Does UnitedHealth Deserve More Credit for Q4?

When UnitedHealth reported mixed fourth-quarter financial results before the markets opened on Wednesday.

Douglas A. McIntyre | Jan 15, 2020 at 6:20 AM EST

Growing Number of Americans Still Don’t Think Vaccines Are Important

Some Americans believe that vaccinations are more dangerous than the diseases they prevent. The number is growing, says Gallup.

1 … 71 72 73 74 75 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Are Investors Overreacting to This Achromatopsia Study?

Why This Cardiovascular Disease Study Could Be Huge

Some Great News for Potential Alzheimer’s Treatment

Why Johnson & Johnson Stock Is Not Reacting More Positively to Earnings

China’s Coronavirus Could Prompt Buying Frenzy in These Biotech Stocks

FDA Fast Track on Lung Cancer Treatment Brings Exponential Gains for This Microcap Stock

Winning Ideas in Biotech/Pharma After JPMorgan Healthcare Conference

China Virus: A Black Swan?

This Week’s Biggest Biotech Movers

What’s Next for Durect After FDA Posimir Vote

Are Neon Therapeutics’ Shareholders Getting Enough in the Buyout?

Why This Opioid Painkiller Is Killing Nektar Therapeutics Stock

Does FDA Decision Mean a Bright Future for This Flu Vaccine?

Does UnitedHealth Deserve More Credit for Q4?

Growing Number of Americans Still Don’t Think Vaccines Are Important

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

Health and Healthcare Articles

All Health and Healthcare Articles

Are Investors Overreacting to This Achromatopsia Study?

Why This Cardiovascular Disease Study Could Be Huge

Some Great News for Potential Alzheimer’s Treatment

Why Johnson & Johnson Stock Is Not Reacting More Positively to Earnings

China’s Coronavirus Could Prompt Buying Frenzy in These Biotech Stocks

FDA Fast Track on Lung Cancer Treatment Brings Exponential Gains for This Microcap Stock

Winning Ideas in Biotech/Pharma After JPMorgan Healthcare Conference

China Virus: A Black Swan?

This Week’s Biggest Biotech Movers

What’s Next for Durect After FDA Posimir Vote

Are Neon Therapeutics’ Shareholders Getting Enough in the Buyout?

Why This Opioid Painkiller Is Killing Nektar Therapeutics Stock

Does FDA Decision Mean a Bright Future for This Flu Vaccine?

Does UnitedHealth Deserve More Credit for Q4?

Growing Number of Americans Still Don’t Think Vaccines Are Important

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

Featured Reads

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up